Scarica l'app Stockscreener
115.68
2.73%
3.07
Dopo l'orario di chiusura:
115.00
-0.68
-0.59%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMDX Giù?
Forum
Previsione
Precedente Chiudi:
$112.61
Aprire:
$112.92
Volume 24 ore:
861.11K
Relative Volume:
0.83
Capitalizzazione di mercato:
$3.94B
Reddito:
$531.29M
Utile/perdita netta:
$71.66M
Rapporto P/E:
59.82
EPS:
1.9338
Flusso di cassa netto:
$17.35M
1 W Prestazione:
+2.39%
1M Prestazione:
-2.91%
6M Prestazione:
+35.49%
1 anno Prestazione:
-10.99%
Intervallo 1D:
$110.85
$118.51
Intervallo di 1 settimana:
$107.22
$118.51
Portata 52W:
$55.00
$145.50
Transmedics Group Inc Stock (TMDX) Company Profile
Nome
Transmedics Group Inc
Settore
Industria
Telefono
(978) 552-0900
Indirizzo
200 MINUTEMAN ROAD, ANDOVER, MA
Confronta TMDX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
115.68 | 3.79B | 531.29M | 71.66M | 17.35M | 1.9338 |
|
ABT
Abbott Laboratories
|
127.63 | 231.95B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
97.78 | 142.60B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
369.25 | 141.45B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.04 | 123.83B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
72.65 | 43.07B | 5.69B | 1.41B | 577.90M | 6.9828 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-13 | Iniziato | Jefferies | Buy |
| 2025-09-16 | Iniziato | Evercore ISI | Outperform |
| 2025-09-04 | Iniziato | Stifel | Hold |
| 2024-12-17 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-11-22 | Downgrade | Needham | Buy → Hold |
| 2024-10-29 | Reiterato | Needham | Buy |
| 2024-10-29 | Reiterato | Oppenheimer | Outperform |
| 2024-09-24 | Iniziato | Robert W. Baird | Outperform |
| 2024-08-21 | Iniziato | Needham | Buy |
| 2024-06-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-06-04 | Iniziato | Stephens | Overweight |
| 2024-03-28 | Iniziato | Piper Sandler | Overweight |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2022-08-02 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-10-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-04-07 | Iniziato | Oppenheimer | Outperform |
| 2019-05-28 | Iniziato | Canaccord Genuity | Buy |
| 2019-05-28 | Iniziato | Cowen | Outperform |
| 2019-05-28 | Iniziato | JP Morgan | Overweight |
| 2019-05-28 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Transmedics Group Inc Borsa (TMDX) Ultime notizie
Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
TransMedics Group, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
TransMedics Group, Inc. $TMDX Shares Sold by Vontobel Holding Ltd. - MarketBeat
TransMedics to Report Third Quarter 2025 Financial Results on October 29, 2025 - Prime Publishers, Inc.
Will TransMedics Group Inc. stock outperform value stocks2025 Technical Overview & Stock Portfolio Risk Management - newser.com
Is it time to cut losses on TransMedics Group Inc.Weekly Risk Summary & Precise Buy Zone Tips - newser.com
Backtesting results for TransMedics Group Inc. trading strategiesEarnings Miss & Weekly Breakout Stock Alerts - newser.com
TransMedics Q2 2025 slides reveal 38% revenue growth despite stock dip - Investing.com Nigeria
Earnings call transcript: TransMedics sees strong Q2 2025 growth, stock dips - Investing.com
TransMedics Group Advances Healthcare Amid Nasdaq 100 Index Rise - Kalkine Media
TransMedics Group (TMDX) Ratings Maintained at 'Buy' by Canaccor - GuruFocus
TransMedics Group (NASDAQ:TMDX) Earns "Buy" Rating from Canaccord Genuity Group - MarketBeat
How to use Fibonacci retracement on TransMedics Group Inc.2025 Trading Volume Trends & Community Trade Idea Sharing - newser.com
Total Clarity Wealth Management Inc. Invests $386,000 in TransMedics Group, Inc. $TMDX - MarketBeat
Is TransMedics Group Inc Gaining or Losing Market Support? - Sahm
Signal strength of TransMedics Group Inc. stock in tech scannersGlobal Markets & Daily Chart Pattern Signal Reports - newser.com
Jefferies Initiates TransMedics Group at Buy With $145 Price Target - MarketScreener
Jefferies Initiates Coverage on TransMedics Group (TMDX) with a 'Buy' Rating | TMDX Stock News - GuruFocus
Can swing trading help recover from TransMedics Group Inc. lossesLong Setup & Technical Pattern Alert System - newser.com
TransMedics Group Inc. stock prediction for this weekWeekly Trade Analysis & Risk Controlled Daily Trade Plans - newser.com
TransMedics Group (NASDAQ:TMDX) Earns Buy Rating from Analysts at Jefferies Financial Group - MarketBeat
Jefferies Initiates Coverage of TransMedics Group (TMDX) with Buy Recommendation - Nasdaq
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Reach Out - ACCESS Newswire
Blair William & Co. IL Trims Stock Holdings in TransMedics Group, Inc. $TMDX - MarketBeat
SLT Holdings LLC Makes New Investment in TransMedics Group, Inc. $TMDX - MarketBeat
How to escape a deep drawdown in TransMedics Group Inc.Weekly Earnings Recap & Real-Time Market Sentiment Alerts - newser.com
TransMedics Group, Inc. $TMDX Shares Acquired by Valmark Advisers Inc. - MarketBeat
Detecting price anomalies in TransMedics Group Inc. with AIWeekly Stock Summary & Long-Term Growth Stock Strategies - newser.com
Weiss Ratings Reaffirms Hold (C) Rating for TransMedics Group (NASDAQ:TMDX) - MarketBeat
There's Been No Shortage Of Growth Recently For TransMedics Group's (NASDAQ:TMDX) Returns On Capital - Yahoo Finance
TransMedics Rides New Tech To Outperform The Market - Finimize
Regression analysis insights on TransMedics Group Inc. performanceEarnings Overview Summary & Short-Term Swing Trade Alerts - newser.com
2 Outstanding Healthcare Stocks to Buy and Hold for a Decade - AOL.com
TransMedics Group (NASDAQ:TMDX) Rating Lowered to Hold at Zacks Research - MarketBeat
TransMedics Stock (NASDAQ: TMDX) Q3 Financial Results - AskTraders.com
TransMedics (TMDX) Faces Potential Revenue Shortfall in Q3 - GuruFocus
Global Assets Advisory LLC Sells 12,550 Shares of TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics Group Acquires Aircraft for Organ Transport - TipRanks
Tools to assess TransMedics Group Inc.’s risk profileJuly 2025 Short Interest & Entry Point Confirmation Alerts - newser.com
Leading vs lagging indicators on TransMedics Group Inc. performance2025 AllTime Highs & Safe Entry Point Alerts - newser.com
Is TransMedics Group Inc. forming a reversal patternTrade Entry Report & Weekly Chart Analysis and Guides - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Price momentum metrics for TransMedics Group Inc. explainedM&A Rumor & Weekly High Conviction Ideas - newser.com
TransMedics Group's (NASDAQ:TMDX) Investors Will Be Pleased With Their Enviable 736% Return Over the Last Five Years - 富途牛牛
Published on: 2025-10-03 05:43:58 - newser.com
Is TransMedics Group Inc. stock bottoming outJuly 2025 Chart Watch & Advanced Swing Trade Entry Alerts - newser.com
GC Wealth Management RIA LLC Makes New Investment in TransMedics Group, Inc. $TMDX - MarketBeat
Transmedics Group Inc Azioni (TMDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Transmedics Group Inc Azioni (TMDX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Hassanein Waleed H | President & CEO |
Aug 07 '25 |
Buy |
116.25 |
8,475 |
985,209 |
486,234 |
| Basile Edward M | Director |
Aug 04 '25 |
Option Exercise |
0.70 |
4,143 |
2,900 |
7,009 |
| Basile Edward M | Director |
Aug 04 '25 |
Sale |
125.51 |
4,143 |
519,988 |
2,866 |
1.23%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):